Dmitriy A. Vinarov, Ph.D., M.B.A. is an equity partner with McDonnell Boehnen Hulbert & Berghoff LLP. Dr. Vinarov has a broad range of experience in intellectual property law, including patents, trademarks, unfair competition, copyrights, and trade secrets. Dr. Vinarov’s practice at MBHB encompasses primarily all phases of U.S. and foreign patent prosecution, with an emphasis on pharmaceuticals, biologicals, diagnostics, biochemistry, cell biology, immunology, molecular biology, medical devices, and diagnostics. Dr. Vinarov also provides client counseling in the areas of patentability, freedom-to-operate, infringement, and validity analyses. Dr. Vinarov’s client list includes Fortune 100 companies, mid-size companies, startups, and academic institutions.
Prior to joining MBHB, Dr. Vinarov spent nearly ten years leading the development and commercialization of the cell-free protein expression technology at the Center for Eukaryotic Structural Genomics at the University of Wisconsin-Madison, Ehime University in Matsuyama, Japan, and the CellFree Sciences Co. in Yokohama, Japan. Dr. Vinarov also served as a scientific and business consultant to a variety of companies in the U.S., U.K., and Japan.
J.D., Marquette University Law School
M.B.A., Marquette University Graduate School of Management
Ph.D., University of Notre Dame,
Biochemistry; Thesis: Reaction mechanism and role of metal ions in yeast enolase catalysis.